TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16870970

Group type: EXPERIMENTAL
Intervention: Peer-based case management
Number of subjects: 137

Group type: COMPARATOR
Intervention: Regular case management
Number of subjects: 137
Study: 12494164

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard therapy (diuretics and ACE inhibitors or ARBs)
Number of subjects: 51
Study: 9922681

Group type: EXPERIMENTAL
Intervention: Combination of a topical and a systemic antibiotic
Number of subjects: 5639

Group type: EXPERIMENTAL
Intervention: Topical antimicrobial preparation
Number of subjects: 5639
Study: 8526833

Group type: EXPERIMENTAL
Intervention: Lake Louise AMS self‐report questionnaire
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Hackett AMS questionnaire
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Environmental Symptoms Questionnaire ESQ II
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Environmental Symptoms Questionnaire ESQ IV
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Lake Louise AMS clinical assessment score
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Lake Louise functional score
Number of subjects: 9
Study: 2081171

Group type: EXPERIMENTAL
Intervention: 2 g of piperacillin 30 minutes before the operation
Number of subjects: 181

Group type: COMPARATOR
Intervention: 4 g of piperacillin 30 minutes before the operation
Number of subjects: 181
Study: 6781794

Group type: EXPERIMENTAL
Intervention: Administration of enantate testosterone and valerianate estradiol
Number of subjects: 25

Group type: COMPARATOR
Intervention: Basal conditions
Number of subjects: 25
Study: 29813149

Group type: EXPERIMENTAL
Intervention: Daily oral vitamin D3 supplementation of 1200 IU
Number of subjects: 975

Group type: COMPARATOR
Intervention: Daily oral vitamin D3 supplementation of 400 IU
Number of subjects: 975
Study: 27814853

Group type: EXPERIMENTAL
Intervention: Manual therapy protocol with emphasis on techniques of joint mobilization and soft-tissue management
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 16
Study: 24469611

Group type: EXPERIMENTAL
Intervention: 3‐session social learning and cognitive-behavioral treatment (N=100)
Number of subjects: 200

Group type: COMPARATOR
Intervention: 3‐session educational intervention controlling for time and attention (N=100)
Number of subjects: 200
Study: 22484579

Group type: EXPERIMENTAL
Intervention: Nicorandil (10 mg through a nasogastric tube 30 minutes before induction of anesthesia)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (10 mL normal saline)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control
Number of subjects: 50
Study: 20537493

Group type: EXPERIMENTAL
Intervention: FFR-guided PCI
Number of subjects: 1005

Group type: COMPARATOR
Intervention: Angiography-guided PCI
Number of subjects: 1005
Study: 17630161

Group type: EXPERIMENTAL
Intervention: Laparoscopic hysterectomy
Number of subjects: 76

Group type: COMPARATOR
Intervention: Abdominal hysterectomy
Number of subjects: 76
Study: 15452587

Group type: EXPERIMENTAL
Intervention: GPR50(Delta502-505) deletion variant in female subjects with BPAD
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: GPR50(Delta502-505) deletion variant in female subjects with MDD
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: SNP in exon 2 in female subjects with MDD
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Intronic SNP in female subjects with SCZ
Number of subjects: 264
Study: 12106829

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Reduction of alcohol consumption by 60%
Number of subjects: 61
Study: 9926170

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 23
Study: 8058235

Group type: EXPERIMENTAL
Intervention: Alprazolam (0.25 mg three times a day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 0
Study: 2564011

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA, 600 mg/day)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 31724959

Group type: EXPERIMENTAL
Intervention: His bundle pacing (HBP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 0
Study: 29596951

Group type: EXPERIMENTAL
Intervention: Vildagliptin (50 mg twice daily)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Gliclazide MR (60-120 mg once daily)
Number of subjects: 42
Study: 28625366

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR) with commercially available balloon-expandable or self-expandable device
Number of subjects: 0

Group type: COMPARATOR
Intervention: Historical surgical aortic valve replacement patients (control group)
Number of subjects: 0
Study: 25639838

Group type: EXPERIMENTAL
Intervention: Teriparatide (TPTD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Switch from Alendronate (ALN) to Teriparatide (TPTD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Add Teriparatide (TPTD) to Alendronate (ALN)
Number of subjects: 0
Study: 24056141

Group type: EXPERIMENTAL
Intervention: Tissue adhesive
Number of subjects: 132

Group type: COMPARATOR
Intervention: Surgical staples
Number of subjects: 132
Study: 22092732

Group type: EXPERIMENTAL
Intervention: 0.1% 8-methoxypsoralen (8MOP) cream before NBUVB phototherapy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Narrowband ultraviolet B (NBUVB) alone
Number of subjects: 10
Study: 19501777

Group type: EXPERIMENTAL
Intervention: Positive information about the wine prior to tasting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Negative information about the wine prior to tasting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Information given after tasting
Number of subjects: 0
Study: 16978159

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 microg/kg bolus followed by 0.4 microg/kg/h infusion)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 15515511

Group type: EXPERIMENTAL
Intervention: Unilateral cuff-compression of the proximal calf (Study group)
Number of subjects: 32

Group type: COMPARATOR
Intervention: No compression (Control group)
Number of subjects: 32
Study: 10642718

Group type: EXPERIMENTAL
Intervention: Köper-knitted polyester graft
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: warp-knitted polyester graft
Number of subjects: 34
Study: 9503527

Group type: EXPERIMENTAL
Intervention: Immunosorption (IS) with perfusion of whole blood through activated charcoal containing DNA
Number of subjects: 11

Group type: COMPARATOR
Intervention: Nonselective hemosorption (control)
Number of subjects: 11
Study: 7722567

Group type: EXPERIMENTAL
Intervention: Accelerated rehabilitation program
Number of subjects: 252

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 252
Study: 2691690

Group type: EXPERIMENTAL
Intervention: Sulindac
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 241364

Group type: EXPERIMENTAL
Intervention: SAS 643
Number of subjects: 0

Group type: COMPARATOR
Intervention: Flurazepam
Number of subjects: 0
Study: 30759117

Group type: EXPERIMENTAL
Intervention: Spirulina supplementation added to soya-maize-based porridge for 12 months (n = 251)
Number of subjects: 501

Group type: COMPARATOR
Intervention: Soya-maize-based porridge for 12 months (n = 250)
Number of subjects: 501
Study: 28347291

Group type: EXPERIMENTAL
Intervention: Individually tailored low-to-moderate intensity exercise with or without behaviour change techniques
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Individually tailored high intensity exercise with or without behaviour change techniques
Number of subjects: 600
Study: 25190674

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 40 mg
Number of subjects: 1039
Study: 23607215

Group type: EXPERIMENTAL
Intervention: 800 ml/day of remaxol
Number of subjects: 141

Group type: COMPARATOR
Intervention: Ringer solution and 10% glucose at 1:1 ratio
Number of subjects: 141
Study: 20009943

Group type: EXPERIMENTAL
Intervention: lotrafilcon B contact lenses
Number of subjects: 54
Study: 18628107

Group type: EXPERIMENTAL
Intervention: Focal hand dystonia (FHD)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no known neuromuscular condition)
Number of subjects: 18
Study: 15897341

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG)
Number of subjects: 28
Study: 12621572

Group type: EXPERIMENTAL
Intervention: Moist Exposed Burn Ointment (MEBO) application
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical antibiotic ointment application
Number of subjects: 0

Group type: COMPARATOR
Intervention: No topical therapy
Number of subjects: 0
Study: 10505286

Group type: EXPERIMENTAL
Intervention: Direct PTCA
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Thrombolysis
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Direct PTCA with coronary stenting
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Direct PTCA in cardiogenic shock
Number of subjects: 4000
Study: 7697233

Group type: EXPERIMENTAL
Intervention: Aerosolized pentamidine (600 mg/d)
Number of subjects: 367

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX) (15 mg/kg/d of trimethoprim plus 75 mg/kg/d of sulfamethoxazole)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Aerosolized pentamidine
Number of subjects: 367

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Aerosolized pentamidine and Trimethoprim-sulfamethoxazole (TMP-SMX)
Number of subjects: 367
Study: 2546484

Group type: EXPERIMENTAL
Intervention: Intrapleural bacillus Calmette‐Guérin (BCG)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 339786

Group type: EXPERIMENTAL
Intervention: Fenoterol
Number of subjects: 19

Group type: COMPARATOR
Intervention: Isoproterenol
Number of subjects: 19
Study: 31927698

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol
Number of subjects: 0
Study: 31710304

Group type: EXPERIMENTAL
Intervention: Symptom exploration strategy
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: High-quality websites
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Internet browsing
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Sharing information with physician
Number of subjects: 155
Study: 28117875

Group type: EXPERIMENTAL
Intervention: Topical capsaicin 8% (24-hour pretreatment)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Topical capsaicin 8% (1-hour pretreatment)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Vehicle control (24-hour application)
Number of subjects: 16
Study: 26003433

Group type: EXPERIMENTAL
Intervention: Dual therapy (rivaroxaban and ticagrelor)
Number of subjects: 420

Group type: COMPARATOR
Intervention: Triple therapy (warfarin, clopidogrel, and aspirin)
Number of subjects: 420
Study: 23232491

Group type: EXPERIMENTAL
Intervention: Gemcitabine and carboplatin with cediranib (30 mg daily)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Gemcitabine and carboplatin without cediranib
Number of subjects: 87
Study: 21592058

Group type: EXPERIMENTAL
Intervention: Rivastigmine (acute)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Rivastigmine (chronic)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 19336558

Group type: EXPERIMENTAL
Intervention: Highest serum retinol concentrations
Number of subjects: 692

Group type: COMPARATOR
Intervention: Lowest serum retinol concentrations
Number of subjects: 692
Study: 16704649

Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg kg(‐1) induction at weeks 0, 2 and 6 followed by maintenance every 8 weeks
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Infliximab maintenance therapy
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Infliximab treatment
Number of subjects: 378

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 378
Study: 15549203

Group type: EXPERIMENTAL
Intervention: Suicide methods in East Germany
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Suicide methods in West Germany
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of suicide methods between East and West Germany
Number of subjects: 0
Study: 10830449

Group type: EXPERIMENTAL
Intervention: Intervention group (low-saturated-fat, low-cholesterol diet)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group (standard diet)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 138
Study: 9129564

Group type: EXPERIMENTAL
Intervention: Oral methylnaltrexone (19.2 mg/kg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Intravenous morphine (0.05 mg/kg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Oral methylnaltrexone (6.4 mg/kg)
Number of subjects: 14
Study: 8399073

Group type: EXPERIMENTAL
Intervention: IL‐2, 9 mIU/m2/day by continuous intravenous infusion on days 1‐5, 8‐12, and 15‐19 with doxorubicin, 25 mg/m2 on day 14.
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: IL‐2, 13.5 mIU/m2/day by continuous intravenous infusion on days 1‐5, 8‐12, and 15‐19 with doxorubicin, 25 mg/m2 on day 14.
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: IL‐2, 18 mIU/m2/day by continuous intravenous infusion on days 1‐5 and 8‐12 with doxorubicin, 50 mg/m2 on day 7.
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: IL‐2, 18 mIU/m2/day by continuous intravenous infusion on days 1‐5 and 8‐12 with doxorubicin, 25 mg/m2 on day 7.
Number of subjects: 15
Study: 2868549

Group type: EXPERIMENTAL
Intervention: Aspirin plus dipyridamole (Persantine)
Number of subjects: 890

Group type: COMPARATOR
Intervention: Aspirin plus placebo
Number of subjects: 890
Study: 29561248

Group type: EXPERIMENTAL
Intervention: Simultaneous administration of PPSV23 and QIV
Number of subjects: 162

Group type: COMPARATOR
Intervention: Sequential administration of PPSV23 and QIV (control)
Number of subjects: 162
Study: 27236330

Group type: EXPERIMENTAL
Intervention: Systematic Community Engagement (SCE) interventions
Number of subjects: 234

Group type: COMPARATOR
Intervention: Control group (no SCE interventions)
Number of subjects: 234
Study: 23983230

Group type: EXPERIMENTAL
Intervention: Multi-component, multi-site intervention for dementia caregivers
Number of subjects: 498

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 498
Study: 22784926

Group type: EXPERIMENTAL
Intervention: Education of GPs on regional diabetes management guidelines
Number of subjects: 361

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 361
Study: 20584682

Group type: EXPERIMENTAL
Intervention: Narcotrend index monitoring
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard hemodynamic parameters
Number of subjects: 40
Study: 18666056

Group type: EXPERIMENTAL
Intervention: Burr-hole craniostomy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Twist drill craniostomy
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study: 15953576

Group type: EXPERIMENTAL
Intervention: L-arginine (1 g/min)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 12814997

Group type: EXPERIMENTAL
Intervention: beta-carotene and retinol supplementation
Number of subjects: 18314

Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 18314
Study: 10397411

Group type: EXPERIMENTAL
Intervention: CO2 inhalation for 20 minutes in panicking subjects with panic disorder
Number of subjects: 24

Group type: COMPARATOR
Intervention: CO2 inhalation for 20 minutes in normal comparison subjects
Number of subjects: 24

Group type: COMPARATOR
Intervention: CO2 inhalation for 20 minutes in non-panicking panic disorder patients
Number of subjects: 24
Study: 8897217

Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no guided imagery)
Number of subjects: 52
Study: 1801561

Group type: EXPERIMENTAL
Intervention: Gamma-globulin treatment
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Intact type gamma-globulin
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control group (no gamma-globulin or indomethacin)
Number of subjects: 143
Study: 6141186

Group type: EXPERIMENTAL
Intervention: Flutroline hydrochloride (1, 5, 10, 20, and 100 mg daily)
Number of subjects: 48
Study: 31000774

Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 55374

Group type: COMPARATOR
Intervention: ADHD genetic liability
Number of subjects: 55374
Study: 30524035

Group type: EXPERIMENTAL
Intervention: Very low load free flow condition (15/0)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Very low load condition with 40% arterial occlusion pressure (15/40)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Very low load condition with 80% arterial occlusion pressure (15/80)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Traditional high load condition (70/0)
Number of subjects: 90
Study: 27310568

Group type: EXPERIMENTAL
Intervention: Affect-guided physical activity prescription
Number of subjects: 67

Group type: COMPARATOR
Intervention: Heart rate-guided prescription
Number of subjects: 67
Study: 24988515

Group type: EXPERIMENTAL
Intervention: Caffeinated drinks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Decaffeinated drinks
Number of subjects: 14
Study: 22810163

Group type: EXPERIMENTAL
Intervention: Critical Time Intervention (CTI)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual services
Number of subjects: 150
Study: 19138702

Group type: EXPERIMENTAL
Intervention: Cocaine infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (saline infusion)
Number of subjects: 0
Study: 17974109

Group type: EXPERIMENTAL
Intervention: Chemically modified SLA surface implants
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard SLA surface implants
Number of subjects: 31
Study: 15472817

Group type: EXPERIMENTAL
Intervention: Micafungin 50 mg per day
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Micafungin 100 mg per day
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Micafungin 150 mg per day
Number of subjects: 245

Group type: COMPARATOR
Intervention: Fluconazole 200 mg per day
Number of subjects: 245
Study: 11743140

Group type: EXPERIMENTAL
Intervention: High glycemic index carbohydrate diet (30% fat)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: High glycemic index carbohydrate diet (20% fat)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Low glycemic index carbohydrate diet (30% fat)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Low glycemic index carbohydrate diet (20% fat)
Number of subjects: 9

Group type: COMPARATOR
Intervention: All diets during the oral glucose tolerance test (GTT)
Number of subjects: 9

Group type: COMPARATOR
Intervention: All diets (24-hr glucose and insulin profiles)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Diets A and C (area under the curve for leptin between 1230 and 2400 hr)
Number of subjects: 9
Study: 9626121

Group type: EXPERIMENTAL
Intervention: 50 mg DHEA
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 100 mg DHEA
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 7843202

Group type: COMPARATOR
Intervention: Subcutaneous erythropoietin (n = 5)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intraperitoneal erythropoietin (IP1) (n = 8)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intraperitoneal erythropoietin (IP2) (n = 8)
Number of subjects: 21
Study: 2979247

Group type: EXPERIMENTAL
Intervention: 40 mg nocte
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 20 mg b.d.
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 40 mg b.d.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30292875

Group type: EXPERIMENTAL
Intervention: Community-based daycare program (n=80)
Number of subjects: 3041
Study: 26686968

Group type: EXPERIMENTAL
Intervention: Amniotic membrane transplantation (AMT) with medical therapy (MT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard medical therapy (MT) alone
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Amniotic membrane transplantation (AMT)
Number of subjects: 25
Study: 25291577

Group type: EXPERIMENTAL
Intervention: H7N9 vaccine (3.75 µg) with MF59 adjuvant
Number of subjects: 700

Group type: COMPARATOR
Intervention: H7N9 vaccine (15 µg) with MF59 adjuvant
Number of subjects: 700

Group type: COMPARATOR
Intervention: H7N9 vaccine (unadjuvanted)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: H7N9 vaccine (various doses)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: H7N9 vaccine (with adjuvant)
Number of subjects: 700
Study: 22591968

Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Photoselective vaporization
Number of subjects: 80
Study: 20881504

Group type: EXPERIMENTAL
Intervention: NaHCO3 (0.3 g·kg‐1)
Number of subjects: 14

Group type: COMPARATOR
Intervention: NaCl placebo (PLAC)
Number of subjects: 14
Study: 18564953

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Naturopathic Medicine (NM)
Number of subjects: 160

Group type: COMPARATOR
Intervention: TCM
Number of subjects: 160

Group type: COMPARATOR
Intervention: NM
Number of subjects: 160
Study: 16085658

Group type: EXPERIMENTAL
Intervention: Bug Buster kit
Number of subjects: 133

Group type: COMPARATOR
Intervention: Over the counter pediculicides
Number of subjects: 133
Study: 12585711

Group type: EXPERIMENTAL
Intervention: Growth hormone replacement therapy
Number of subjects: 5
Study: 10613000

Group type: EXPERIMENTAL
Intervention: Non-Indian reviewers
Number of subjects: 78

Group type: COMPARATOR
Intervention: Indian reviewers
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Non-Indian reviewers (non-exchanged group)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Non-Indian reviewers (exchanged group)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Non-Indian reviewers (exchanged)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Indian reviewers (exchanged)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Overall assessment by editors
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Time taken to return reviews
Number of subjects: 78